Article
The inflammatory response of human pancreatic cancer samples compared to normal controls
1 Nov 2023
Abstract excerpt
Pancreatic ductal adenocarcinoma (PDAC) is a poor prognosis cancer with an aggressive growth profile that is often diagnosed at late stage and that has few curative or therapeutic options. PDAC growth has been linked to alterations in the pancreas microbiome, which could include the presence of the fungus Malassezia. We used RNA-sequencing to compare 14 matched tumor and normal (tumor adjacent) pancreatic cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
